Market Closed -
Nyse
21:00:02 26/04/2024 BST
|
5-day change
|
1st Jan Change
|
16.1
USD
|
+2.48%
|
|
+7.62%
|
+2.03%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
188.6
|
448.4
|
1,647
|
780.2
|
1,204
|
1,236
|
-
|
-
|
Enterprise Value (EV)
1 |
188.1
|
435.6
|
1,647
|
780.2
|
1,180
|
1,279
|
1,553
|
1,236
|
P/E ratio
|
-12.9
x
|
-20.1
x
|
-40.8
x
|
-5.61
x
|
-23.9
x
|
-84.7
x
|
22.8
x
|
12.2
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
1.35
x
|
4.47
x
|
13.5
x
|
4.33
x
|
5.04
x
|
3.41
x
|
2.09
x
|
1.46
x
|
EV / Revenue
|
1.35
x
|
4.34
x
|
13.5
x
|
4.33
x
|
4.94
x
|
3.53
x
|
2.63
x
|
1.46
x
|
EV / EBITDA
|
-1,075
x
|
-68.4
x
|
-63.4
x
|
-12.9
x
|
-51.4
x
|
39.3
x
|
12.6
x
|
6.84
x
|
EV / FCF
|
-59.4
x
|
-32.7
x
|
-50.8
x
|
-2.86
x
|
-5.41
x
|
-9.3
x
|
-14.4
x
|
-13.4
x
|
FCF Yield
|
-1.68%
|
-3.06%
|
-1.97%
|
-34.9%
|
-18.5%
|
-10.8%
|
-6.97%
|
-7.44%
|
Price to Book
|
3.2
x
|
6.84
x
|
11.8
x
|
1.05
x
|
2.47
x
|
2.58
x
|
2.25
x
|
-
|
Nbr of stocks (in thousands)
|
24,300
|
26,868
|
33,079
|
66,173
|
76,318
|
76,762
|
-
|
-
|
Reference price
2 |
7.760
|
16.69
|
49.79
|
11.79
|
15.78
|
16.10
|
16.10
|
16.10
|
Announcement Date
|
20/02/20
|
18/02/21
|
17/02/22
|
15/02/23
|
12/02/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
139.4
|
100.3
|
121.6
|
180.4
|
238.7
|
362.1
|
591
|
844.9
|
EBITDA
1 |
-0.175
|
-6.367
|
-25.98
|
-60.64
|
-22.93
|
32.58
|
122.8
|
180.8
|
EBIT
1 |
-14.16
|
-21.57
|
-40.6
|
-79.24
|
-49.2
|
-5.593
|
69.59
|
124.4
|
Operating Margin
|
-10.16%
|
-21.51%
|
-33.38%
|
-43.94%
|
-20.61%
|
-1.54%
|
11.78%
|
14.72%
|
Earnings before Tax (EBT)
1 |
-14.56
|
-21.81
|
-37.09
|
-82.74
|
-45.81
|
-14.27
|
55.54
|
123
|
Net income
1 |
-14.56
|
-21.81
|
-37.09
|
-82.74
|
-45.81
|
-14.27
|
54.69
|
106.7
|
Net margin
|
-10.45%
|
-21.75%
|
-30.5%
|
-45.87%
|
-19.19%
|
-3.94%
|
9.25%
|
12.63%
|
EPS
2 |
-0.6000
|
-0.8300
|
-1.220
|
-2.100
|
-0.6600
|
-0.1900
|
0.7075
|
1.315
|
Free Cash Flow
1 |
-3.166
|
-13.34
|
-32.41
|
-272.4
|
-218.1
|
-137.6
|
-108.2
|
-92
|
FCF margin
|
-2.27%
|
-13.3%
|
-26.64%
|
-151.01%
|
-91.35%
|
-38%
|
-18.3%
|
-10.89%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
20/02/20
|
18/02/21
|
17/02/22
|
15/02/23
|
12/02/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
30.38
|
31.48
|
38.41
|
45.64
|
36.71
|
59.61
|
45.59
|
48.16
|
60.76
|
84.22
|
75.37
|
83.96
|
96.46
|
106.4
|
121.9
|
EBITDA
1 |
-7.83
|
-12.15
|
-14.67
|
-18.32
|
-23.19
|
-4.464
|
-13.94
|
-10.83
|
-7.295
|
9.132
|
2.337
|
6.562
|
10.5
|
13.08
|
20.47
|
EBIT
1 |
-11.5
|
-16.31
|
-18.62
|
-22.65
|
-28.31
|
-9.666
|
-18.91
|
-17.04
|
-14.63
|
1.383
|
-7.29
|
-3.658
|
1.35
|
4.164
|
4.1
|
Operating Margin
|
-37.85%
|
-51.83%
|
-48.49%
|
-49.62%
|
-77.12%
|
-16.22%
|
-41.48%
|
-35.39%
|
-24.09%
|
1.64%
|
-9.67%
|
-4.36%
|
1.4%
|
3.91%
|
3.36%
|
Earnings before Tax (EBT)
1 |
-7.822
|
-16.35
|
-19.48
|
-24.05
|
-29.6
|
-9.609
|
-16.8
|
-15.42
|
-13.07
|
-0.519
|
-9.044
|
-5.497
|
-1.018
|
1.276
|
1
|
Net income
1 |
-7.822
|
-16.35
|
-19.48
|
-24.05
|
-29.6
|
-9.609
|
-16.8
|
-15.42
|
-13.07
|
-0.519
|
-8.276
|
-4.94
|
-0.8407
|
0.5617
|
1.684
|
Net margin
|
-25.75%
|
-51.96%
|
-50.73%
|
-52.7%
|
-80.63%
|
-16.12%
|
-36.84%
|
-32.03%
|
-21.52%
|
-0.62%
|
-10.98%
|
-5.88%
|
-0.87%
|
0.53%
|
1.38%
|
EPS
2 |
-0.2400
|
-0.5000
|
-0.5900
|
-0.6800
|
-0.7500
|
-0.2000
|
-0.2400
|
-0.2200
|
-0.1900
|
-0.0100
|
-0.1088
|
-0.0662
|
-0.0150
|
0.006250
|
0.0550
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
28/10/21
|
17/02/22
|
27/04/22
|
27/07/22
|
26/10/22
|
15/02/23
|
03/05/23
|
02/08/23
|
01/11/23
|
12/02/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
43.5
|
317
|
-
|
Net Cash position
1 |
0.51
|
12.8
|
-
|
-
|
24.7
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
1.335
x
|
2.581
x
|
-
|
Free Cash Flow
1 |
-3.17
|
-13.3
|
-32.4
|
-272
|
-218
|
-138
|
-108
|
-92
|
ROE (net income / shareholders' equity)
|
-22.5%
|
-34.4%
|
-21.1%
|
-28.9%
|
-9.79%
|
-2.2%
|
10.7%
|
-
|
ROA (Net income/ Total Assets)
|
-14.4%
|
-21.7%
|
-29.1%
|
-19.9%
|
-6.8%
|
-1.5%
|
8.95%
|
-
|
Assets
1 |
101.3
|
100.5
|
127.4
|
414.8
|
673.2
|
951.5
|
611.1
|
-
|
Book Value Per Share
2 |
2.430
|
2.440
|
4.220
|
11.30
|
6.380
|
6.240
|
7.170
|
-
|
Cash Flow per Share
2 |
-0.0400
|
-0.3800
|
-0.6100
|
-2.400
|
-0.6100
|
0.3500
|
1.430
|
-
|
Capex
1 |
2.11
|
3.42
|
13.8
|
178
|
175
|
78.8
|
237
|
168
|
Capex / Sales
|
1.52%
|
3.41%
|
11.33%
|
98.67%
|
73.5%
|
21.75%
|
40.07%
|
19.89%
|
Announcement Date
|
20/02/20
|
18/02/21
|
17/02/22
|
15/02/23
|
12/02/24
|
-
|
-
|
-
|
Last Close Price
16.1
USD Average target price
20.3
USD Spread / Average Target +26.09% Consensus |
1st Jan change
|
Capi.
|
---|
| +2.03% | 1.24B | | +11.47% | 63.22B | | -3.47% | 46.34B | | +13.72% | 39.97B | | +17.83% | 25.46B | | +7.27% | 18.68B | | -0.57% | 17.24B | | -21.73% | 15.81B | | +0.22% | 14.9B | | -19.10% | 13.74B |
Other Specialty Chemicals
|